These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17418083)

  • 1. Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box.
    Lineberry TW; Bostwick JM; Beebe TJ; Decker PA
    Mayo Clin Proc; 2007 Apr; 82(4):518-20. PubMed ID: 17418083
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant prescribing practices for the treatment of children and adolescents.
    Bhatia SK; Rezac AJ; Vitiello B; Sitorius MA; Buehler BA; Kratochvil CJ
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):70-80. PubMed ID: 18294090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antidepressants and suicide -- did the FDA Black Box Warning back fire?].
    Rihmer Z
    Psychiatr Hung; 2014; 29(3):252-6. PubMed ID: 25411222
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatricians and antidepressant medications: black box or black hole?
    Wegner LM
    Pediatrics; 2005 Jul; 116(1):233-5. PubMed ID: 15995060
    [No Abstract]   [Full Text] [Related]  

  • 7. More data needed to interpret link between suicide and FDA warning on antidepressants.
    Case BG
    BMJ; 2014 Oct; 349():g5616. PubMed ID: 25301797
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S; Gersing KR; Erkanli A; Burt T
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proxy for suicide attempts was inappropriate in study of changes in antidepressant use after FDA warnings.
    Bartlett RO
    BMJ; 2014 Oct; 349():g5644. PubMed ID: 25301794
    [No Abstract]   [Full Text] [Related]  

  • 10. Study findings on FDA antidepressant warnings and suicide attempts in young people: a false alarm?
    Barber C; Azrael D; Miller M
    BMJ; 2014 Oct; 349():g5645. PubMed ID: 25301785
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychopharmacology news.
    Silva RR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):531-2. PubMed ID: 17822347
    [No Abstract]   [Full Text] [Related]  

  • 12. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis.
    Greenhouse JB; Kelleher KJ
    Pediatrics; 2005 Jul; 116(1):231-3. PubMed ID: 15995059
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of study of changes in antidepressant use after FDA warnings is not reliable.
    Gøtzsche PC
    BMJ; 2014 Oct; 349():g5623. PubMed ID: 25300434
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning.
    Hassanin H; Harbi A; Saif A; Davis J; Easa D; Harrigan R
    Hawaii Med J; 2010 Jan; 69(1):17-9. PubMed ID: 20222492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impossible to draw meaningful conclusions from study of changes in antidepressant use after FDA warnings.
    Nardo JM
    BMJ; 2014 Oct; 349():g5643. PubMed ID: 25301791
    [No Abstract]   [Full Text] [Related]  

  • 16. Reservations about study on antidepressant use by young people and suicidal behaviour after FDA warnings.
    Mosholder AD; Taylor LG; Crentsil V
    BMJ; 2014 Oct; 349():g6503. PubMed ID: 25355684
    [No Abstract]   [Full Text] [Related]  

  • 17. Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable.
    Olfson M; Schoenbaum M
    BMJ; 2014 Oct; 349():g5614. PubMed ID: 25301267
    [No Abstract]   [Full Text] [Related]  

  • 18. Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings.
    Lacy BW; Baron DA; Goin MK; Gross LS; Slaby AE; Sumner CR
    J Am Osteopath Assoc; 2013 Feb; 113(2):117-9. PubMed ID: 23412671
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning.
    Cook BL; Wang Y; Sonik R; Busch S; Carson N; Progovac AM; Zaslavsky AM
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):255-262. PubMed ID: 30666633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M; Marcus SC; Shaffer D
    Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.